Previous 10 | Next 10 |
PerkinElmer (NYSE:PKI) says that the new Omicron variant will not impact the accuracy of its PCR tests to detect COVID-19. In silico assessment against variant databases have confirm that none of the mutations associated with Omicron impact the company's PerkinElmer's PCR based diagnostic kit...
Diagnostic accuracy of PerkinElmer’s COVID-19 PCR tests remains unaffected PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the performance of its SARS-CoV-2 RT-PCR assays are not impacted by th...
The revolutionary technology of synthetic biology is poised to make a profound impact on the way a vast array of products are manufactured, from lab-grown meat to cosmetics to biodegradable packaging. Like the internet revolution, companies that enable or effectively harness synthetic...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Evercore ISI 4th Annual HealthCONx Conference 2021 on Wednesday, December 1, 2021 at 10:30 a.m. ET. Prahlad Singh, president and chi...
PerkinElmer has seen tremendous growth as a result of COVID testing, resulting in a 189% increase in free cash flow in 2020. The company has used the surge in cash flow to fund a series of acquisitions, which should offset the decline in COVID-related revenue. The share price has ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Goldman Sachs (NYSE:GS) built out its thematic ETF lineup with the launch Thursday of three new funds -- the Goldman Sachs Future Consumer Equity ETF (NYSEARCA:GBUY), Goldman Sachs Future Health Care Equity ETF (NYSEARCA:GDOC) and the Goldman Sachs Future Real Estate and Infrastructure Equity...
Image source: The Motley Fool. PerkinElmer, Inc (NYSE: PKI) Q3 2021 Earnings Call Nov 5, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: PerkinElmer, Inc (PKI) Q3 2021 Earnings Call Transcript
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: PerkinElmer, Inc. 2021 Q3 - Results - Earnings Call Presentation
PerkinElmer, Inc. (PKI) Q3 2021 Earnings Conference Call November 02, 2021 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief Executive Officer James Mock - Senior Vice President and Chief Financial Officer Peter Wrigh...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...